• Our Offering
    • Pharma & Biotech

      Our LPBN segment offers clinical development services, clinical and commercial manufacturing in biologics and small molecule businesses, alongside consumables and research tools.

    • Capsules & Health Ingredients

      Our CHI business delivers oral dosage forms alongside nutritional ingredients for the consumer health market.

    • Microbial Control Solutions

      Our MCS business delivers future-proof Microbial Control technologies and related applications to consumer-facing and resource protection markets.

    • Specialty Chemical Services

      Our SCS business delivers solutions in technically demanding industries and applications, alongside capabilities in custom development and manufacturing.

  • About Us
    • Company Overview

      • Our Vision and Strategy
      • Our Leadership
      • Our History
      • Our Locations
      • Our Websites
      • Events
    • News and Media

      • News Archive
      • Image Library
      • Logo Guidelines
      • Leadership Portraits
      • Videos
      • A View On - Podcast
      • Media Inquiries
    • Investor Relations

      • Shareholder Information
      • Agenda and Events
      • Financial Reporting
      • Corporate Governance
      • Ethics and Compliance
      • Investor Inquiries
    • Sustainability

      • Performance
      • People
      • Environment
      • Community
      • Global Quality
  • Careers
    • Overview

      We are here to make a Meaningful Difference. It is the foundation of the way we do business. A career at Lonza is more than a job. We do not just work in the life sciences industries, we are transforming them. What we do today is helping to create a healthier, happier world tomorrow.

    • Life at Lonza

      • What We Offer
      • Career Stories
    • Job Search

      • Recruitment Process
      • Students, Graduates and Apprentices
      • Join Us To Control COVID-19
  • Contact
Our Offering
Pharma & Biotech
Capsules & Health Ingredients
Microbial Control Solutions
Specialty Chemical Services
About Us
Company Overview
  • Our Vision and Strategy
  • Our Leadership
  • Our History
  • Our Locations
  • Our Websites
  • Events
News and Media
  • News Archive
  • Image Library
  • Logo Guidelines
  • Leadership Portraits
  • Videos
  • A View On - Podcast
  • Media Inquiries
Investor Relations
  • Shareholder Information
  • Agenda and Events
  • Financial Reporting
  • Corporate Governance
  • Ethics and Compliance
  • Investor Inquiries
Sustainability
  • Performance
  • People
  • Environment
  • Community
  • Global Quality
Careers
Overview
Life at Lonza
  • What We Offer
  • Career Stories
Job Search
  • Recruitment Process
  • Students, Graduates and Apprentices
  • Join Us To Control COVID-19
Contact

News Archive

    • Company Overview
    • News and Media
    • Investor Relations
    • Sustainability
    • Careers
  • News and Media
    • A View On - Lonza Podcast
    • Image Library
    • Leadership Portraits
    • Videos
    • Logo Guidelines
    • Media Inquiries
  • News Archive
Filter by News Category
General (4) Acquisitions (2) Financials (1)
Filter by Market
Agro Ingredients (6) Wood Protection (2) Consumer Care (1) Corporate (1) Hygiene (1)
Filter by Year
2021 (1) 2018 (3) 2016 (1) 2015 (1)
Filter by Language
English (6)
Agro IngredientsX
EnglishX
Showing 1‐6 of 6
results per page
08 Feb 2021
Lonza Signs Agreement to Divest Specialty Ingredients Business to Bain Capital and Cinven
Lonza Specialty Ingredients to be sold to Bain Capital and Cinven for an enterprise value of CHF 4.2 billionDivestment will allow Lonza to refocus...
19 Oct 2018
Lonza Announces Short, Routine Shutdown of Niacinamide Plant in Nansha (CN) for Maintenance
Basel, Switzerland, 19 October 2018 – Lonza today announced that it will shut down its production of Niacinamide (vitamin B3) in Nansha (CN) in...
30 May 2018
Lonza Showcases Chemical Technologies and China Blue Sky Solutions at Chemspec Europe 2018
Lonza to feature its wide range of offerings for chemical supplies, including key raw materials that address the needs of customers affected by the...
23 Mar 2018
Lonza Announces Routine Shutdown of Niacin Plant in Visp (CH) for Maintenance
Visp, Switzerland, 23 March 2018 – Lonza today announced that it will shut down its production of niacin in Visp (CH) for some weeks during April...
16 Mar 2016
Lonza and Nulandis Sign Strategic Distribution Agreement to Launch Innovative Axcela® Slug & Snail Pellet in South Africa
Johannesburg, South Africa / Basel, Switzerland, 16 March 2016 – Lonza, the global market leader in molluscicide business, and Nulandis, a division...
03 Aug 2015
Lonza Acquires Research-Focused Chemical Company Zelam Based in New Zealand

Our Offering

  • Pharma & Biotech
  • Capsules & Health Ingredients
  • Microbial Control Solutions
  • Specialty Chemical Services

About Us

  • Company
  • News and Media
  • Investor Relations
  • Sustainability
  • Events

Careers

  • Overview
  • Life at Lonza
  • Career Stories
  • Apply

Utilities

  • Contact
  • Legal Disclaimer
  • Privacy Policy
  • Sitemap
© 2021 Lonza. All rights reserved.
By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy and Cookie policies.